163 related articles for article (PubMed ID: 8424465)
1. Clear cell sarcoma of the kidney expresses insulinlike growth factor-II but not WT1 transcripts.
Yun K
Am J Pathol; 1993 Jan; 142(1):39-47. PubMed ID: 8424465
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
Yun K; Fidler AE; Eccles MR; Reeve AE
Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
[TBL] [Abstract][Full Text] [Related]
4. Comparative reverse transcription-polymerase chain reaction and in situ hybridization analyses of human imprinted p57KIP2 and insulin-like growth factor 2 gene transcripts in fetal kidney and Wilms' tumors using archival tissue.
Soejima H; McLay J; Hatada I; Mukai T; Jinno Y; Niikawa N; Yun K
Lab Invest; 1998 Jan; 78(1):19-28. PubMed ID: 9461119
[TBL] [Abstract][Full Text] [Related]
5. Expression of WT1 protein in fetal kidneys and Wilms tumors.
Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE
Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503
[TBL] [Abstract][Full Text] [Related]
6. Detection of anti-sense transcripts of the insulin-like growth factor-2 gene in Wilms' tumor.
Baccarini P; Fiorentino M; D'Errico A; Mancini AM; Grigioni WF
Am J Pathol; 1993 Dec; 143(6):1535-42. PubMed ID: 8256846
[TBL] [Abstract][Full Text] [Related]
7. A new marker for rhabdomyosarcoma. Insulin-like growth factor II.
Yun K
Lab Invest; 1992 Nov; 67(5):653-64. PubMed ID: 1434543
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
[TBL] [Abstract][Full Text] [Related]
9. [Demonstration of the differential expression of IGF-II in various embryonal kidney tumors using slot-blot hybridization and in-situ hybridization].
Briner J; Hassam S; Rohrer R
Verh Dtsch Ges Pathol; 1990; 74():419-23. PubMed ID: 1708629
[TBL] [Abstract][Full Text] [Related]
10. Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms' tumor. An in situ hybridization study.
Paik S; Rosen N; Jung W; You JM; Lippman ME; Perdue JF; Yee D
Lab Invest; 1989 Nov; 61(5):522-6. PubMed ID: 2554059
[TBL] [Abstract][Full Text] [Related]
11. Expression of nine developmental stage-specific genes in human kidney and cultured renal cells.
Haltia A; Solin ML; Muramatsu T; Jalanko H; Holmberg C; Miettinen A; Holthöfer H
Exp Nephrol; 1997; 5(6):457-64. PubMed ID: 9438174
[TBL] [Abstract][Full Text] [Related]
12. Comparative in situ hybridization analysis of PAX2, PAX8, and WT1 gene transcription in human fetal kidney and Wilms' tumors.
Eccles MR; Yun K; Reeve AE; Fidler AE
Am J Pathol; 1995 Jan; 146(1):40-5. PubMed ID: 7856737
[TBL] [Abstract][Full Text] [Related]
13. Expression of WT-1, Bcl-2, and CD34 by primary renal spindle cell tumors in children.
Shao L; Hill DA; Perlman EJ
Pediatr Dev Pathol; 2004; 7(6):577-82. PubMed ID: 15630525
[TBL] [Abstract][Full Text] [Related]
14. Human sarcomatous Wilms' tumor lines: evidence for epithelial differentiation in clear cell sarcoma of the kidney.
Ishii E; Fujimoto J; Hara S; Tanaka S; Hata J
Cancer Res; 1989 Oct; 49(19):5392-9. PubMed ID: 2475248
[TBL] [Abstract][Full Text] [Related]
15. WT1 expression alters tumorigenicity of the G401 kidney-derived cell line.
McMaster ML; Gessler M; Stanbridge EJ; Weissman BE
Cell Growth Differ; 1995 Dec; 6(12):1609-17. PubMed ID: 9019166
[TBL] [Abstract][Full Text] [Related]
16. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
Takahashi M; Yang XJ; Lavery TT; Furge KA; Williams BO; Tretiakova M; Montag A; Vogelzang NJ; Re GG; Garvin AJ; Söderhäll S; Kagawa S; Hazel-Martin D; Nordenskjold A; Teh BT
Cancer Res; 2002 Nov; 62(22):6598-605. PubMed ID: 12438255
[TBL] [Abstract][Full Text] [Related]
18. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
[TBL] [Abstract][Full Text] [Related]
19. Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways.
Cutcliffe C; Kersey D; Huang CC; Zeng Y; Walterhouse D; Perlman EJ;
Clin Cancer Res; 2005 Nov; 11(22):7986-94. PubMed ID: 16299227
[TBL] [Abstract][Full Text] [Related]
20. Two molecular subgroups of Wilms' tumors with or without WT1 mutations.
Schumacher V; Schuhen S; Sonner S; Weirich A; Leuschner I; Harms D; Licht J; Roberts S; Royer-Pokora B
Clin Cancer Res; 2003 Jun; 9(6):2005-14. PubMed ID: 12796362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
